---
$id: https://graph.org.ai/products/commodity/51111640
$type: Product
source: UNSPSC
code: "51111640"
title: "Masoprocol"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Masoprocol

**UNSPSC Code**: 51111640
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a lipooxygenase inhibitor and antioxidant with the molecular formula C18H22O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BO8G1BYQU, chemically known as 1,2-benzenediol, 4,4-(2,3-dimethyl-1,4-butanediyl)bis-, (r*,s*)- but generally known as masoprocol, which bears US NIH Compound Identifier 71398. European Medicines Agency schedules Masoprocol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08652MIG. The term MASOPROCOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules masoprocol in its Anatomical Therapeutic Chemical (ATC) Classification. MASOPROCOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule masoprocol under HS 29072900 and SITC 51243. As of Q4 2014, MASOPROCOL remains the US FDA Preferred Term for this commodity. Masoprocol bears US NLM identifiers UMLS ID C0733397 and NCI Concept Code C701. SMILES: OC1CC(CC(C(CC2CC(O)C(O)CC2)C)C)CCC1O.

